📄 Extracted Text (1,343 words)
Report Status: Partial
raj Quest
Diagnostics EPSTEIN, JEFFREY
Patient Information Specimen Information Chentheonnation
Specimen: MR495703L Client #: 78300020 56W5265
EPSTEIN, JEFFREY
Requisition: 0006136 MOSKOWITZ,BRUCE W
DOB: 01/20/1953 AGE: 65 BRUCE MOSKOWITZ,MD
Gender: M Attn: NATIONWIDE ACCOUNT
Collected: 08/30/2018
Phone: 1411 N FLAGLER DR STE 7100
Received: 08/31/2018 115:51 EDT
Patient ID: 19530120MJE WEST PALM BEACH,FL 33401.3418
Reported: 08/31/2018 123:33 EDT
Health ID: 8573003290851249
Teat Name In Range Out Of Range Reference Range Lab
LIPID PANEL, STANDARD
CHOLESTEROL, TOTAL 219 H <200 mg/dL MI
HDL CHOLESTEROL 29 L >40 mg/dL MI
TRIGLYCERIDES 475 H <150 mg/dL MI
LDL-CHOLESTEROL mg/dL (talc) MI
LDL cholesterol not calculated. Triglyceride levels
greater than 400 mg/dL invalidate calculated LDL results.
Reference range: <100
Desirable range <100 mg/dL for primary prevention;
<70 mg/dL for patients with CHD or diabetic patients
with > or = 2 CHD risk factors.
LDL-C is now calculated using the Martin-Hopkins
calculation, which is a validated novel method providing
better accuracy than the Friedewald equation in the
estimation of LDL-C.
Martin SS et al. JAMA. 2013;310(19): 2061-2068
(http://education.QuestDiagnostics.com/faq/FAQ164)
CHOL/HDLC RATIO 7.6 H <5.0 (talc) MI
NON HDL CHOLESTEROL 190 H <130 mg/dL (talc) MI
For patients with diabetes plus 1 major ASCVD risk
factor, treating to a non-HDL-C goal of <100 mg/dL
(LDL-C of <70 mg/dL) is considered a therapeutic
option.
HS CRP 0.9 mg/L TP
Lower relative cardiovascular risk according to
AHA/CDC guidelines.
For ages >17 Years:
hs-CRP mg/L Risk According to AHA/CDC Guidelines
<1.0 Lower relative cardiovascular risk.
1.0-3.0 Average relative cardiovascular risk.
3.1-10.0 Higher relative cardiovascular risk.
Consider retesting in 1 to 2 weeks to
exclude a benign transient elevation
in the baseline CRP value secondary
to infection or inflammation.
>10.0 Persistent elevation, upon retesting,
may be associated with infection and
inflammation.
HOMOCYSTEINE 11.6 H <11.4 umol/L MI
Homocysteine is increased by functional deficiency of
folate or vitamin B12. Testing for methylmalonic acid
differentiates between these deficiencies. Other causes
of increased homocysteine include renal failure, folate
antagonists such as methotrexate and phenytoin, and
exposure to nitrous oxide.
CLIENT SERVICES:866.697.8378 SPECIMEN: MR495703L PAGEI0F5
Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics.
EFTA00304878
Report Status: Partial
Quest
Diagnostics EPSTEIN, JEFFREY
Patient Information Specimen Information Client Information
Specimen: MR495703L Client #: 78300020
EPSTEIN, JEFFREY
Collected: 08/30/2018 MOSKOWITZ. BRUCE W
DOB: 01/20/1953 AGE: 65 Received: 08/31/2018 / 15:51 EDT
Gender: M Reported: 08/31/2018 /23:33 EDT
Patient ID: 19530120MJE
Health ID: 8573003290851249
Test Name In Range Out Of Range Reference Range Lab
COMPREHENSIVE METABOLIC MI
PANEL
GLUCOSE 105 R 65-99 mg/dL
Fasting reference interval
For someone without known diabetes, a glucose value
between 100 and 125 mg/dL is consistent with
prediabetes and should be confirmed with a
follow-up test.
UREA NITROGEN (BUN) 19 7-25 mg/dL
CREATININE 0.98 0.70-1.25 mg/dL
For patients >49 years of age, the reference limit
for Creatinine is approximately 13₹ higher for people
identified as African-American.
eGFR NON-AFR. AMERICAN 81 > OR = 60 mL/min/1.73m2
eGFR AFRICAN AMERICAN 93 > OR = 60 mL/min/1.73m2
BUN/CREATININE RATIO NOT APPLICABLE 6-22 (calc)
SODIUM 141 135-146 mmol/L
POTASSIUM 4.5 3.5-5.3 mmol/L
CHLORIDE 108 98-110 mmol/L
CARBON DIOXIDE 23 20-32 mmol/L
CALCIUM 9.4 8.6-10.3 mg/dL
PROTEIN, TOTAL 7.0 6.1-8.1 g/dL
ALBUMIN 4.1 3.6-5.1 g/dL
GLOBULIN 2.9 1.9-3.7 g/dL (calc)
ALBUMIN/GLOBULIN RATIO 1.4 1.0-2.5 (calc)
BILIRUBIN, TOTAL 0.8 0.2-1.2 mg/dL
ALKALINE PHOSPHATASE 59 40-115 U/L
AST 25 10-35 U/L
ALT 36 9-46 U/L
HEMOGLOBIN Alc MI
See Endnote 1
PHOSPHATE (AS PHOSPHORUS) 3.4 2.1-4.3 mg/dL MI
URIC ACID 8.1 H 4.0-8.0 mg/dL MI
Therapeutic target for gout patients: <6.0 mg/dL
TSH 2.03 0.40-4.50 mIU/L MI
T4 (THYROXINE), TOTAL 8.0 4.9-10.5 mcg/dL MI
FREE T4 INDEX (T7) 2.4 1.4-3.8
T3 UPTAKE 30 22-35 % MI
SED RATE BY MODIFIED MI
WESTERGREN 9 < OR = 20 mm/h
CBC (INCLUDES DIFF/PLT) MI
WHITE BLOOD CELL COUNT 5.7 3.8-10.8 Thousand/uL
RED BLOOD CELL COUNT 5.11 4.20-5.80 Million/uL
HEMOGLOBIN 15.5 13.2-17.1 g/dL
HEMATOCRIT 44.6 38.5-50.0 %
MCV 87.3 80.0-100.0 fL
MCH 30.3 27.0-33.0 pg
MCHC 34.8 32.0-36.0 g/dL
RDW 13.8 11.0-15.0 %
PLATELET COUNT 271 140-400 Thousand/uL
CLIENTSERIIICES:866.6971378 SPECIMEN: MR495703L PAGE 2OF 5
Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics.
EFTA00304879
Report Status: Partial
4) Quest
Diagnostics EPSTEIN, JEFFREY
Patient Information Specimen Information Client Information
Specimen: MR495703L Client #: 78300020
EPSTEIN, JEFFREY
Collected: 08/30/2018 MOSKOWITZ. BRUCE W
DOB: 01/20/1953 AGE: 65 Received: 08/31/2018 / 15:51 EDT
Gender: M Reported: 08/31/2018 / 23:33 EDT
Patient ID: 19530120MJE
Health ID: 8573003290851249
Test Name In Range Out Of Range Reference Range Lab
MPV 9.7 7.5-12.5 fL
ABSOLUTE NEUTROPHILS 2582 1500-7800 cells/uL
ABSOLUTE LYMPHOCYTES 2177 850-3900 cells/uL
ABSOLUTE MONOCYTES 502 200-950 cells/uL
ABSOLUTE EOSINOPHILS 371 15-500 cells/uL
ABSOLUTE BASOPHILS 68 0-200 cells/uL
NEUTROPHILS 45.3
LYMPHOCYTES 38.2
MONOCYTES 8.8
EOSINOPHILS 6.5
BASOPHILS 1.2
URINALYSIS, COMPLETE MI
See Endnote 2
VITAMIN B12 383 200-1100 pg/mL MI
Please Note: Although the reference range for vitamin
B12 is 200-1100 pg/mL, it has been reported that between
5 and 10% of patients with values between 200 and 400
pg/mL may experience neuropsychiatric and hematologic
abnormalities due to occult B12 deficiency; less than 1₹
of patients with values above 400 pg/mL will have symptoms.
C-REACTIVE PROTEIN 1.1 <8.0 mg/L MI
TESTOSTERONE, TOTAL MI
MALES (ADULT), IA
TESTOSTERONE, TOTAL,
MALES (ADULT), IA 122 L 250-827 ng/dL
In hypogonadal males, Testosterone, Total, LC/MS/MS,
is the recommended assay due to the diminished
accuracy of immunoassay at levels below 250 ng/dL.
This test code (15983) must be collected in a
red-top tube with no gel.
PSA, TOTAL 0.6 < OR = 4.0 ng/mL MI
The total PSA value from this assay system is
standardized against the WHO standard. The test
result will be approximately 20% lower when compared
to the equimolar-standardized total PSA (Beckman
Coulter). Comparison of serial PSA results should be
interpreted with this fact in mind.
This test was performed using the Siemens
chemiluminescent method. Values obtained from
different assay methods cannot be used
interchangeably. PSA levels, regardless of
value, should not be interpreted as absolute
evidence of the presence or absence of disease.
Endnote I
* Test not performed.
* Quantity not sufficient. *
Endnote 2
* Test not performed.
* No specimen received. *
CLIENT SERVICES: 866.697.8378 SPECIMEN: MR495703L PAGE30F5
Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics.
EFTA00304880
Report Status: Partial
raj Quest
Diagnostics EPSTEIN, JEFFREY
Patient Information Specimen Information Client Information
Specimen: MR495703L Client #: 78300020
EPSTEIN, JEFFREY
Collected: 08/30/2018 MOSKOWITZ. BRUCE W
DOB: 01/20/1953 AGE: 65 Received: 08/31/2018 / 15:51 EDT
Gender: M Reported: 08/31/2018 / 23:33 EDT
Patient ID: 19530120MJE
Health ID: 8573003290851249
CLIENT SERVICES: 866.697.8378 SPECIMEN: MR495703L PAGE 4 OF 5
Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics.
EFTA00304881
Report Status: Partial
raj Quest
Diagnostics EPSTEIN, JEFFREY
Patient Information Specimen Information Client Information
Specimen: MR495703L Client #: 78300020
EPSTEIN, JEFFREY
Collected: 08/30/2018 MOSKOWITZ, BRUCE W
DOB: 01/20/1953 AGE: 65 Received: 08/31/2018 / 15:51 EDT
Gender: M Reported: 08/31/2018 / 23:33 EDT
Patient ID: 19530120MJE
Health ID: 8573003290851249
Endocrinology
Test Name Result Reference Range Lab
VITAMIN D,25.OH,TOTAL,IA 30 30-100 ng/mL MI
Vitamin D Status 25-OH Vitamin D:
Deficiency: <20 ng/mL
Insufficiency: 20 - 29 ng/mL
Optimal: > or = 30 ng/mL
For 25-OH Vitamin D testing on patients on D2-supplementation and patients for whom quantitation of D2 and D3 fractions is required, the
QuestAssureD(TM) 25-OH VIT D, (D2,D3), LC/MS/MS is recommended: order code 92888 (patients >2yrs).
For more information on this test, go to: http://education.questdiagnostics.com/faq/FAQ163 (This link is being provided for informational/
educational purposes only.)
Physician Comments:
PENDING TESTS:
LIPOPROTEIN (a) MERCURY. BLOOD
PERFORMING SITE:
MI QUEST DIAGNOSTICS.MIM.H. 10330 COMMERCE PARKWAY. MIRAMAR. FL 33025.3938 Laboratory Director: GLEN L HORTIN MD PHD. CLIA: I0002773M
TP QUEST DIAGNOSTICSTAMPA. 1225 E FOWLER AVE TAMPA. It 33617:2026 Laboratory Doctor GLEN L IIORTIN.MD.PIID. CLIA: 101)0291120
CLIENT SERVICES: 866.697.8378 SPECIMEN: MR495703L PAGE 5 OF 5
Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics.
EFTA00304882
ℹ️ Document Details
SHA-256
a1d236dcd5ef318ebeafaa380dc038eb9c3f59bab46041bebb53494fd5ad89d7
Bates Number
EFTA00304878
Dataset
DataSet-9
Document Type
document
Pages
5
Comments 0